Glaucoma – Don’t turn a blind eye to the disease!

Glaucoma is categorised as a disorder that affects the function of the eye. The characteristics of Glaucoma produce specific signs and symptoms, and ultimately share a single common feature, progressive optic neuropathy (Damage to the optic nerve).  All manifestations of Glaucoma can result in progressive loss of vision if untreated, or undetected, eventually this can be potentially blinding.

Incorporating the Glaucoma’s as a group of diseases, they are now the leading source of visual morbidity, affecting more than 60 million people throughout the world.  What’s more, around 8.4 ... read more

Read More

Glaucoma Awareness Week 7th – 13th June 2010

Glaucoma is one of the leading causes of preventable blindness, believed to affect more than 70 million people worldwide. A study by the National research strategy for ophthalmology discovered that 500,000 people in England and Wales alone suffer from some type of Glaucoma, that’s about two out of 100 people over the age of 40, and astonishingly half of these people are gradually losing their sight and completely unaware of their condition. Future Sight Loss UK who analyze the incidence, distribution and possible control of diseases and other factors relating to health found that the dete... read more

Read More

Stem Cell Contact Lenses Help Blind Patients See Again

Three patients in Australia have had their eyesight restored through the use of contact lenses cultured with the patient’s own stem cells collected from their working eye according to The Australian journal.

Stem cell research is a very exciting prospect in the medical world right now.  Stem Cells are special cells that have the ability to grow into adult tissue, they are the foundation for every organ, tissue and cell in the human body.

Research suggests that stem cells may be able to repair or replace damaged tissue, thereby reversing diseases and injuries such as ca... read more

Read More

Sight-Saving Drug for Patients in England.

Eye Closeup

Patients in England suffering from a disease which causes blindness are to get access to a sight-saving drug.

The Lucentis drug treats ‘wet’ age-related Macular Degeneration, the leading cause of sight loss in the country.

What is Age-Related Macular Degeneration (AMD)? AMD is a disease associated with aging that gradually destroys sharp, central vision making difficult or even impossible to see objects clearly in common daily tasks such as reading and driving. AMD affects the macula, the part of the eye that allows you to see fine details. AMD is a painless ... read more

Read More